Clinical Trial Update: Shiga Microalbuminuria Reduction Trial-2 [Phase 4]

View source ↗

Summary

Phase 4 trial update for Shiga Microalbuminuria Reduction Trial-2; completed with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Type 2 Diabetes Mellitus

Snippet

Sponsor: Shiga University | Conditions: Type 2 Diabetes Mellitus, Hypertension | Phase 4 | Status: COMPLETED | Results posted: 2018-02-19